Pfizer

FDA rejects Pfizer Herceptin biosimilar, wants technical info

https://pharmaphorum.com/news/fda-rejects-pfizer-herceptin-biosimilar-wants-technical-info/

Explore New Strategies to Maintain a Global Pharmacovigilance System by Pfizer

https://pharmaphorum.com/partner-content/explore-new-strategies-to-maintain-a-global-pharmacovigilance-system-by-pfizer/

Pfizer’s lung cancer drug dacomitinib gets fast US review

https://pharmaphorum.com/news/pfizers-lung-cancer-drug-dacomitinib-gets-fast-us-review/

Quick Update – Under 2 Weeks Remaining – ADC Conference

https://pharmaphorum.com/partner-content/quick-update-under-2-weeks-remaining-adc-conference/

GSK left as sole bidder for Pfizer consumer health unit

https://pharmaphorum.com/news/reckitt-benckiser-ends-bid-pfizer-consumer-health-unit/

Pfizer eyes gastro use for Xeljanz after thumbs-up from FDA advisers

https://pharmaphorum.com/news/pfizer-eyes-gastro-use-xeljanz-thumbs-fda-advisers/

BMS seizes Opdivo dosing advantage over Keytruda

https://pharmaphorum.com/news/bms-opdivo-gets-monthly-dosing-schedule-as-duel-with-merck-intensifies/

Pfizer might buy BMS for $130bn – but should it?

https://pharmaphorum.com/news/pfizer-might-buy-bms-for-130bn-but-should-it/

J&J gets quick approval for new next-gen prostate cancer drug

https://pharmaphorum.com/news/jj-gets-quick-approval-new-next-gen-prostate-cancer-drug/

Close in 10 seconds

Pharmaphorum.com

Search